Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

A religious movement that has so often taken public stands has been unusually quiet since Trump gutted the program to combat ...

Medically reviewed by Renita White, MD Mouth and tongue lesions are often one of the first symptoms of human immunodeficiency ...

Lucas County urges residents to get tested for HIV, STIs. Early detection saves lives and prevents further spread.

June 27 isn’t just another summer day — it’s HIV Testing Day. Across the country, this day shines a spotlight on something ...

Sally Gunnell is relishing her latest challenge aimed at banishing the stigma around HIV, admitting she continues to feel ...

Word In Black Mystkue Woods words to encourage, educate, and embolden folks take initiative in their sexual health journey by changing ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent effectiveness in trials. Here's how it works, and what it costs.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.